• KPT330 Enhances CRISPR-Cas9 Specificity via mRNA Nuclear Exp

  2026-05-01

  The referenced study identifies KPT330 as a small molecule that enhances the specificity of CRISPR-Cas9 genome and base editing by selectively inhibiting Cas9 mRNA nuclear export. This mechanism offers a new approach to reduce off-target effects in genome editing applications, expanding the toolkit for precise genetic engineering.

• Irinotecan (CPT-11): Mechanistic Insights and Translational

  2026-05-01

  This thought-leadership article explores the mechanistic underpinnings and translational potential of Irinotecan (CPT-11) in colorectal cancer research. Integrating recent findings on DNA damage, apoptosis induction, and emerging challenges such as chemotherapy-induced steatohepatitis, the article offers actionable guidance for researchers using APExBIO Irinotecan (A5133). It bridges foundational mechanisms with evolving demands in preclinical modeling, competitive benchmarking, and strategic foresight for next-generation translational studies.

• X-Gal for Blue-White Colony Screening: Applied Protocols & I

  2026-04-30

  Unlock the full power of X-Gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside) for blue-white colony screening with advanced troubleshooting and workflow enhancements. Evidence-backed protocols and real-world troubleshooting help ensure high-fidelity molecular cloning and β-galactosidase assays—driven by APExBIO’s high-purity X-Gal and the latest research in gene regulation.

• Human iPSC-Derived Sensory Neurons Model HSV-1 Latency and R

  2026-04-30

  This study establishes human iPSC-derived sensory neurons as a scalable, physiologically relevant in vitro model for HSV-1 latent infection and reactivation. The work enables new avenues for mechanistic virology studies and preclinical testing of therapeutic strategies targeting HSV-1 latency.

• EZ Cap™ Human PTEN mRNA (ψUTP): Optimizing mRNA Stability in

  2026-04-29

  EZ Cap™ Human PTEN mRNA (ψUTP) sets a new benchmark for restoring tumor suppressor activity in challenging cancer models, thanks to advanced mRNA stability enhancement and immune evasion. This guide details experimental workflows and troubleshooting strategies, leveraging recent nanoparticle delivery breakthroughs to reverse drug resistance and streamline PTEN re-expression studies.

• PLAC1 as a Prognostic Biomarker and Target in ccRCC: Insight

  2026-04-29

  The reference study identifies PLAC1 as a novel prognostic biomarker and actionable molecular target in clear cell renal cell carcinoma (ccRCC) using multi-omic analyses and high-throughput virtual screening (HTVS). The findings highlight the therapeutic relevance of targeting PLAC1 and demonstrate the utility of computational compound discovery workflows for advancing precision oncology.

• Angiotensin III: Optimizing RAAS Peptide Workflows in Resear

  2026-04-28

  Angiotensin III (human, mouse) is a uniquely bioactive RAAS peptide, enabling precise dissection of AT1 and AT2 receptor signaling in cardiovascular and neuroendocrine models. This guide translates the latest mechanistic findings into actionable protocols, advanced applications, and troubleshooting insights—empowering researchers to maximize reproducibility and biological insight using APExBIO’s high-purity peptide.

• Recombinant Human EGF: Precision Control for Tumor Spheroid

  2026-04-28

  Explore how recombinant human Epidermal Growth Factor (EGF) enables precise, standardized 3D tumor spheroid assays and stemness evaluation, surpassing conventional cell culture models. Grounded in recent protocol innovations, this article delivers practical, evidence-backed guidance.

• Cl-Amidine (trifluoroacetate salt): PAD4 Inhibition in Disea

  2026-04-27

  Cl-Amidine trifluoroacetate salt is a potent, selective PAD4 inhibitor that enables precise modulation of histone citrullination. It demonstrates significant efficacy in preclinical cancer and inflammatory disease models, supporting targeted epigenetic research.

• BIIE 0246: Precision NPY Y2 Receptor Antagonism in Applied R

  2026-04-27

  BIIE 0246, a potent neuropeptide Y Y2 receptor antagonist from APExBIO, empowers researchers to dissect presynaptic inhibitory mechanisms, satiety circuits, and the adipose-neural axis in both neural and cardiometabolic contexts. This guide translates recent breakthroughs and expert troubleshooting into actionable workflows for enhanced experimental precision and reproducibility.

• MLN8237 (Alisertib) in Aneugenicity Profiling and Advanced C

  2026-04-26

  Explore how MLN8237 (Alisertib) enables advanced dissection of Aurora A kinase’s role in oncogenesis, with a unique focus on aneugenicity profiling and assay design. Learn how this selective inhibitor shapes next-generation cancer biology research.

• Meropenem: β-Lactam Antibiotic Carbapenem for Resistance Mod

  2026-04-25

  Meropenem stands as an ultra-broad-spectrum β-lactam antibiotic carbapenem, enabling rigorous, reproducible research on Gram-negative and Gram-positive bacterial resistance. This guide details experimental workflows, troubleshooting, and comparative insights for optimizing antibacterial assays and infection models using Meropenem from APExBIO.

• Aprotinin (BPTI): Applied Workflows for Fibrinolysis Inhibit

  2026-04-24

  Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI) delivers precise, reversible inhibition of key serine proteases, enabling robust perioperative blood loss reduction and advanced inflammation modulation in cardiovascular research. This guide details actionable protocols, troubleshooting strategies, and experimental insights—bridging biophysical fundamentals with translational blood management.

• Panoramic Opto-Electrical Mapping for Mouse Cardiac Research

  2026-04-24

  Rieger et al. introduce a panoramic opto-electrical measurement and stimulation (POEMS) system enabling simultaneous, high-resolution optical and electrical mapping of mouse hearts. This innovation streamlines the integration of optogenetic tools and electrophysiological assays, supporting advanced studies of cardiac conduction, cell-type interactions, and arrhythmia mechanisms.

• Nocodazole in Host-Pathogen Interaction: Microtubule Inhibit

  2026-04-23

  Explore Nocodazole as a microtubule polymerization inhibitor in the context of host-pathogen dynamics. This article delves into cutting-edge applications for infection modeling, offering a unique perspective beyond cell cycle and cancer research.

11092 records 1/740 page Next 12345 下5页 Last page